Rchr
J-GLOBAL ID:201701006815272756   Update date: Apr. 20, 2024

MOROISHI Toshiro

モロイシ トシロウ | MOROISHI Toshiro
Affiliation and department:
Job title: (Professor)
Homepage URL  (1): https://moroishi-lab.com
Research field  (6): Medical biochemistry ,  Pharmacology ,  Immunology ,  Molecular biology ,  Cell biology ,  Tumor biology
Research keywords  (4): Hippo pathway ,  Iron metabolism ,  Cancer ,  Immunity
Research theme for competitive and other funds  (15):
  • 2024 - 2031 Towards the understanding of cellular community maintained by cell competition and symbiosis
  • 2023 - 2029 DNAイベントレコーダー細胞
  • 2024 - 2027 「適応多様性」研究領域の拡大・発展に向けた総括研究
  • 2024 - 2027 哺乳類の器官形成における「適応多様性」の解明
  • 2023 - 2026 胎児丸ごとの体外培養法を用いた次世代オルガノイドの開発
Show all
Papers (45):
  • Akihiro Nita, Toshiro Moroishi. Hippo pathway in cell-cell communication: emerging roles in development and regeneration. Inflammation and Regeneration. 2024. 44. 1
  • Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita, Shinsei Yumoto, Taichi Horino, Michio Sato, Kazutoyo Terada, Keishi Miyata, Yuki Ichigozaki, Toshihiro Kimura, et al. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy. Cancer gene therapy. 2024
  • Toshiro Moroishi, Chanida Thinyakul, Yasuhisa Sakamoto, Mayuko Shimoda, Yanliang Liu, Suyanee Thongchot, Omnia Reda, Akihiro Nita, Romgase Sakamula, Somponnat Sampattavanich, et al. Hippo pathway in cancer cells modulates tumor microenvironment by inducing immunosuppressive NCAM1+αSMA+ fibroblasts. 2024
  • Hironori Hinokuma, Yohei Kanamori, Koei Ikeda, Li Hao, Masataka Maruno, Taishi Yamane, Ayato Maeda, Akihiro Nita, Mayuko Shimoda, Mayumi Niimura, et al. Distinct functions between ferrous and ferric iron in lung cancer cell growth. Cancer science. 2023
  • Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto, et al. Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression. JCI Insight. 2022. 7. 21
more...
MISC (14):
  • 前田英仁, 諸石寿朗. Hippo経路. がんゲノムペディア. 2024. 71-73
  • 諸石寿朗. ラボ百景:多様なバックグラウンドをもった仲間と多様性の研究を楽しむ. 実験医学. 2023. 41. 13. 2186-2188
  • 金森耀平, 諸石寿朗. 鉄動態の制御と肝癌の進行. 肝胆膵. 2022. 84. 4. 491-496
  • 仁田暁大, 諸石寿朗. 腫瘍免疫の制御における細胞外小胞の二面性-細胞外小胞を利用したがん治療法の開発へ向けて. 実験医学. 2021. 39. 20. 3189-3195
  • 竹島裕貴, 諸石寿朗. Hippo細胞内シグナル伝達経路による組織恒常性の維持機構. 臨床免疫・アレルギー科. 2021. 76. 2. 182-189
more...
Education (2):
  • 2008 - 2012 Kyushu University Graduate School of Medical Sciences
  • 2002 - 2008 Kyushu University Faculty of Medicine
Professional career (1):
  • M.D., Ph.D. (Kyushu University)
Work history (4):
  • 2020/01 - 現在 Kumamoto University Faculty of Life Sciences Professor
  • 2017/12 - 2019/12 Kumamoto University Faculty of Life Sciences Associate Professor
  • 2013/04 - 2017/08 University of California, San Diego, Department of Pharmacology and Moores Cancer Center, Postdoctoral fellow
  • 2012/04 - 2013/03 Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan Postdoctoral fellow
Committee career (2):
  • 2023/04 - 現在 The Japanese Biochemical Society Councilor
  • 2020/04 - 現在 Communications Biology (Springer Nature) Editorial Board Member
Awards (3):
  • 2021/04 - Ministry of Education, Culture, Sports, Science and Technology (MEXT) 科学技術分野の文部科学大臣表彰 若手科学者賞(令和3年度) シグナル伝達と代謝調節による生体恒常性維持機構の研究
  • 2019/06 - The Kao Foundation for Arts and Sciences 花王科学奨励賞(平成31年度) 組織修復・再生を担うHippoシグナルの全貌解明
  • 2013/02 - Inoue Foundation for Science Inoue Research Award for Young Scientists (29th) ユビキチン化による鉄代謝制御の中心をなすFBXL5-IRP2系の発見
Association Membership(s) (5):
The Japanese Pharmacological Society ,  The Japanese Cancer Association ,  Japanese Association of Cancer Immunology ,  The Molecular Biology Society of Japan ,  The Japanese Biochemical Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page